Evidence map›Paper›PMID 42519377›Full record

ArticleFrontiers in cardiovascular medicine2026

Deep learning model to generate patient-specific pulmonary vein isolation lines from successful atrial fibrillation ablation cases: a proof-of-concept study.

Kazuo Sakamoto, Takeshi Tohyama, Hirotake Yokoyama, Tsukasa Watanabe, Tomomi Nagayama, Yasushi Mukai, Shunsuke Kawai, Daisuke Yakabe, Hiroshi Mannoji, Kazuhiro Nagaoka and 11 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kazuo SakamotoDepartment of Cardiovascular Medicine/Coronary Care Unit, Kyushu University Hospital, Fukuoka, Japan.
Takeshi TohyamaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hirotake YokoyamaDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tsukasa WatanabeDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tomomi NagayamaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yasushi MukaiDepartment of Cardiology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
Shunsuke KawaiDepartment of Cardiology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan.
Daisuke YakabeDepartment of Cardiovascular Internal Medicine, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Hiroshi MannojiDepartment of Cardiovascular Medicine, Hamanomachi Hospital, Fukuoka, Japan.
Kazuhiro NagaokaDepartment of Cardiovascular Medicine, St. Mary's Hospital, Fukuoka, Japan.
Atsushi TanakaDivision of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Mitsutaka YamamotoDepartment of Cardiovascular Medicine, Harasanshin Hospital, Fukuoka, Japan.
Kiyohiro OgawaDepartment of Cardiology, Fukuoka City Hospital, Fukuoka, Japan.
Takeshi MikamiDepartment of Cardiology, Munakata Suikokai General Hospital, Fukuoka, Japan.
Shujiro InoueDepartment of Cardiology, Aso Iizuka Hospital, Fukuoka, Japan.
Susumu TakaseDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kei InoueSUSMED, Inc., Tokyo, Japan.
Kazuya HosokawaDepartment of Cardiovascular Medicine/Coronary Care Unit, Kyushu University Hospital, Fukuoka, Japan.
Koji TodakaDepartment of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hiroyuki TsutsuiSchool of Health Sciences, International University of Health and Welfare, Fukuoka, Japan.
Kohtaro AbeDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary vein isolation (PVI) is an established standard ablation for atrial fibrillation (AF), however, AF recurrence remains a major clinical challenge. We developed a deep learning model to generate patient-specific PVI lines on pre-ablation 3D voltage maps, using lesion sets from successful AF ablation cases with documented freedom from recurrence for more than one year as ground truth. Using a U-Net-based architecture trained and evaluated on 513 maps from 171 such cases, the model reproduced the anatomical and electrophysiological features of these PVI lesion sets. On the held-out test set, the model achieved a mean Intersection over Union of 0.87 and a Dice score of 0.93. As a proof of concept, these findings suggest that the model can reproduce patient-specific PVI patterns associated with successful outcomes; whether this translates into reduced recurrence requires prospective clinical validation.

Indexed as

3D voltage mapartificial intelligenceatrial fibrillationcatheter ablationpulmonary vein isolation

Identifiers

PMID42519377
PMCPMC13381618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.